New York State Teachers Retirement System Has $8.24 Million Stake in HealthEquity, Inc. $HQY

Key Points

• The New York State Teachers Retirement System reduced its stake in HealthEquity, Inc. (NASDAQ:HQY) by 7.1% in Q2, holding 78,651 shares valued at approximately $8.24 million.
• HealthEquity reported a net revenue of $325.80 million for the quarter, surpassing analyst estimates, and met earnings expectations with an EPS of $0.92.
• Institutional investors dominate ownership of the stock, with 99.55% of shares held by these entities, highlighting strong interest in HealthEquity's performance.

New York State Teachers Retirement System decreased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 78,651 shares of the company's stock after selling 6,024 shares during the period. New York State Teachers Retirement System owned about 0.09% of HealthEquity worth $8,239,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Mutual Advisors LLC lifted its position in HealthEquity by 13.7% in the 2nd quarter. Mutual Advisors LLC now owns 5,880 shares of the company's stock worth $565,000 after buying an additional 708 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in HealthEquity by 78.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 29,731 shares of the company's stock worth $3,115,000 after buying an additional 13,086 shares in the last quarter. Index Fund Advisors Inc. purchased a new stake in HealthEquity in the 2nd quarter worth approximately $246,000. Vanguard Personalized Indexing Management LLC lifted its position in HealthEquity by 27.0% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 10,639 shares of the company's stock worth $1,115,000 after buying an additional 2,263 shares in the last quarter. Finally, US Bancorp DE lifted its position in HealthEquity by 10.9% in the 2nd quarter. US Bancorp DE now owns 20,351 shares of the company's stock worth $2,132,000 after buying an additional 2,001 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Up 0.5%

HealthEquity stock opened at $91.46 on Monday. The company has a market capitalization of $7.88 billion, a P/E ratio of 55.43, a P/E/G ratio of 1.32 and a beta of 0.47. The firm's fifty day simple moving average is $91.70 and its 200-day simple moving average is $94.10. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HQY has been the subject of a number of research analyst reports. Royal Bank Of Canada increased their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, September 3rd. KeyCorp cut their target price on shares of HealthEquity from $125.00 to $120.00 and set an "overweight" rating for the company in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 3rd. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Jefferies Financial Group raised their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $121.31.

Insiders Place Their Bets

In related news, EVP Delano Ladd sold 6,000 shares of the firm's stock in a transaction on Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president directly owned 79,456 shares in the company, valued at approximately $7,477,604.16. This trade represents a 7.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm's stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.50% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.